Advanced Proteome Therapeutics Announces Appointment of Dr. Benjamin Krantz to Ceo
mcleanap2021-09-09T12:51:12-04:00Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to announce that as previously planned, Dr. Benjamin Krantz has taken over the role of CEO at its US subsidiary, Advanced Proteome Therapeutics Inc. (“APTI”).